MARI.VI
Price:
$19.7
Market Cap:
$35.03M
Marinomed Biotech AG, a biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally. Its products pipeline includes Budesolv for the treatment of allergic rhinitis and autoimmune gastritis; Tacrosolv, which is in Phase II clinical trial for anterior inflammatory eye diseases; Carravin for the treatment of nasal congestion; and Inhaleen that is in Phase I clinical trial for viral pneumonia, as well as Carragelose, which consists of nasal and throat sprays, and lozenges for treating viral respiratory infections. The company was formerly known as Marinomed Biotechnologie GmbH and changed its name t...[Read more]
Industry
Biotechnology
IPO Date
2019-02-01
Stock Exchange
VIE
Ticker
MARI.VI
According to Marinomed Biotech AG’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Marinomed Biotech AG over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), MARI.VI's Dividend Yield was at its highest in in the December 2017 quarter at 0%. The Dividend Yield was at its lowest in in the December 2017 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Marinomed Biotech AG Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
The current Dividend Yield of Marinomed Biotech AG (MARI.VI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Marinomed Biotech AG’s Dividend Yield is
| Company | Dividend Yield | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marinomed Biotech AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Marinomed Biotech AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Marinomed Biotech AG's Dividend Yield?
How is the Dividend Yield calculated for Marinomed Biotech AG (MARI.VI)?
What is the highest Dividend Yield for Marinomed Biotech AG (MARI.VI)?
What is the 3-year average Dividend Yield for Marinomed Biotech AG (MARI.VI)?
What is the 5-year average Dividend Yield for Marinomed Biotech AG (MARI.VI)?
How does the current Dividend Yield for Marinomed Biotech AG (MARI.VI) compare to its historical average?